You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 16, October 22, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (39)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Physical Examination
 •Cardiovascular System
 •Prognosis/ Outcomes
 •Cardiovascular Disease/ Myocardial Infarction
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prognostic Importance of Physical Examination for Heart Failure in Non–ST-Elevation Acute Coronary Syndromes

The Enduring Value of Killip Classification

Umesh N. Khot, MD; Gang Jia, MS; David J. Moliterno, MD; A. Michael Lincoff, MD; Monica B. Khot, MD; Robert A. Harrington, MD; Eric J. Topol, MD

JAMA. 2003;290:2174-2181.

Context  In acute myocardial infarction, the presence and severity of heart failure at the time of initial presentation have been formally categorized by the Killip classification. Although well studied in ST-elevation myocardial infarction, the prognostic importance of Killip classification in non–ST-elevation acute coronary syndromes is not well established.

Objectives  To determine the prognostic importance of physical examination for heart failure analyzed according to Killip classification in non–ST-elevation acute coronary syndromes and to understand its predictive value relative to other variables.

Design, Setting, and Patients  From April 2001 to September 2003, We analyzed information from 26 090 patients with non–ST-elevation acute coronary syndromes enrolled in the GUSTO IIb, PURSUIT, PARAGON A, and PARAGON B trials. Demographic information was categorized by Killip class. Killip classes III and IV were combined into 1 category. Multivariate Cox proportional hazard models were developed to determine the prognostic importance of Killip classification in comparison with other variables.

Main Outcome Measure  Association between Killip classification and all-cause mortality at 30 days and 6 months.

Results  Patients in Killip class II (n = 2513) and III/IV (n = 390) were older than those in Killip class I (n = 23 187), with higher rates of diabetes, prior myocardial infarction, ST depression, and elevated cardiac enzymes (all P<.001). Higher Killip class was associated with higher mortality at 30 days (2.8% in Killip class I vs 8.8% in class II vs 14.4% in class III/IV; P<.001) and 6 months (5.0% vs 14.7% vs 23.0%, respectively; P<.001). Patients with Killip class II, III, or IV constituted 11% of the overall population but accounted for approximately 30% of the deaths at both time points. In multivariate analysis, Killip class III/IV was the most powerful predictor of mortality at 30 days (hazard ratio [HR], 2.35; 95% confidence interval [CI], 1.69-3.26; P<.001) and 6 months (HR, 2.12; 95% CI, 1.63-2.75; P<.001). Killip class II was predictive of mortality at 30 days (HR, 1.73; 95% CI, 1.44-2.09; P<.001) and 6 months (HR, 1.52; 95% CI, 1.31-1.76; P<.001). Five factors—age, Killip classification, heart rate, systolic blood pressure, and ST depression—provided more than 70% of the prognostic information for 30-day and 6-month mortality.

Conclusions  Killip classification is a powerful independent predictor of all-cause mortality in patients with non–ST-elevation acute coronary syndromes. Age, Killip classification, heart rate, systolic blood pressure, and ST depression should receive particular attention in the initial assessment of these patients.


Author Affiliations: Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio (Drs U. Khot, Moliterno, Lincoff, M. Khot, and Topol and Mr Jia); and Duke Clinical Research Institute, Durham, NC (Dr Harrington). Drs U. Khot and M. Khot are now with the Indiana Heart Physicians, Indianapolis.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Takotsubo Cardiomyopathy: A Nurse's Guide
Griffin and Logue
Crit Care Nurse 2009;29:32-42.
FULL TEXT  

Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment.
Flaherty et al.
J Am Coll Cardiol 2009;53:254-263.
ABSTRACT | FULL TEXT  

CHAPTER 23 Heart Failure
McMurray et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT | FULL TEXT  

A Plethora of Prognostic Pearls
Alpert
Circulation 2008;118:1312-1313.
FULL TEXT  

Impact of In-Hospital Revascularization on Survival in Patients With Non-ST-Elevation Acute Coronary Syndrome and Congestive Heart Failure
Steg et al.
Circulation 2008;118:1163-1171.
ABSTRACT | FULL TEXT  

Clinical diagnosis of left ventricular dilatation and dysfunction in the age of technology
Rovai et al.
Eur J Heart Fail 2007;9:723-729.
ABSTRACT | FULL TEXT  

Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better
Yan et al.
Eur Heart J 2007;28:1072-1078.
ABSTRACT | FULL TEXT  

Risk stratification in acute coronary syndromes--does the TIMI risk score work in unselected cases?
Soiza et al.
QJM 2006;99:81-87.
ABSTRACT | FULL TEXT  

Part 5: Acute Coronary Syndromes
Circulation 2005;112:III-55-III-72.
FULL TEXT  

Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry
Szummer et al.
Eur Heart J 2005;26:2114-2119.
ABSTRACT | FULL TEXT  

Percutaneous coronary intervention guidelines: new aspects for the interventional treatment of acute coronary syndromes
Elsasser and Hamm
Eur Heart J Suppl 2005;7:K5-K9.
ABSTRACT | FULL TEXT  

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
Authors/Task Force Members et al.
Eur Heart J 2005;26:1115-1140.
FULL TEXT  

Acute heart failure: Clinical presentation, one-year mortality and prognostic factors
Rudiger et al.
Eur J Heart Fail 2005;7:662-670.
ABSTRACT | FULL TEXT  

Prevalence and Impact of Metabolic Syndrome on Hospital Outcomes in Acute Myocardial Infarction
Zeller et al.
Arch Intern Med 2005;165:1192-1198.
ABSTRACT | FULL TEXT  

Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
Authors/Task Force Members et al.
Eur Heart J 2005;26:804-847.
FULL TEXT  

Heart Failure and Death After Myocardial Infarction in the Community: The Emerging Role of Mitral Regurgitation
Bursi et al.
Circulation 2005;111:295-301.
ABSTRACT | FULL TEXT  

Safety and Efficacy of Surgical Ventricular Restoration in Unstable Patients With Recent Anterior Myocardial Infarction
Di Donato et al.
Circulation 2004;110:II-169-II-173.
ABSTRACT | FULL TEXT  

Killip Class Predicts Death After ACS
Journal Watch Cardiology 2003;2003:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.